<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Classification of pancreatic cysts
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Classification of pancreatic cysts
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Classification of pancreatic cysts
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Asif Khalid, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kevin McGrath, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John R Saltzman, MD, FACP, FACG, FASGE, AGAF
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Shilpa Grover, MD, MPH, AGAF
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 29, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pancreatic cysts are diagnosed with increasing frequency because of the widespread use of cross-sectional imaging. Pancreatic cysts may be detected in 40 to 50 percent of patients who undergo abdominal magnetic resonance imaging for unrelated reasons. The frequency increases with age [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p>
         Pancreatic cysts can either be neoplastic (eg, intraductal papillary mucinous neoplasms) or non-neoplastic. Accurate cyst categorization is important, since non-neoplastic cysts require treatment only if symptomatic, whereas some of the pancreatic cystic neoplasms have significant malignant potential and should be resected.
        </p>
        <p>
         This topic will review the classification of pancreatic cysts. An overview of pancreatic cystic neoplasms and issues related to pancreatic inflammatory fluid collections and intraductal papillary mucinous neoplasms of the pancreas are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5642.html" rel="external">
          "Pancreatic cystic neoplasms: Clinical manifestations, diagnosis, and management"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5651.html" rel="external">
          "Approach to walled-off pancreatic fluid collections in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5650.html" rel="external">
          "Endoscopic interventions for walled-off pancreatic fluid collections"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5632.html" rel="external">
          "Intraductal papillary mucinous neoplasm of the pancreas (IPMN): Pathophysiology and clinical manifestations"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5652.html" rel="external">
          "Clinical manifestations and diagnosis of acute pancreatitis", section on 'Local complications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          TYPES OF PANCREATIC CYSTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cystic lesions of the pancreas can be divided pathologically into inflammatory fluid collections, non-neoplastic pancreatic cysts, and pancreatic cystic neoplasms (PCNs). Rarely, solid pancreatic tumors may also present as a pancreatic cyst (eg, pancreatic neuroendocrine tumor). Most pancreatic cysts are detected incidentally when abdominal imaging is performed for some other indication [
         <a href="#rid1">
          1,2
         </a>
         ]. PCNs account for more than half of pancreatic cysts, even in patients with a history of pancreatitis [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         Pancreatic cystic lesions can be an isolated finding, or they can be associated with an underlying disorder such as von Hippel-Lindau disease or polycystic kidney disease. In a study of 158 consecutive patients with von Hippel-Lindau disease, 77 percent had a pancreatic abnormality, including 70 percent with cysts, 9 percent with serous cystadenomas, and 9 percent with neuroendocrine tumors [
         <a href="#rid4">
          4
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5193.html" rel="external">
          "Clinical features, diagnosis, and management of von Hippel-Lindau disease"
         </a>
         .)
        </p>
        <p>
         Pancreatic cysts are seen in 7 to 10 percent of patients with autosomal dominant polycystic kidney disease. (See
         <a class="medical medical_review" href="/z/d/html/1679.html" rel="external">
          "Autosomal dominant polycystic kidney disease (ADPKD): Extrarenal manifestations", section on 'Pancreatic cysts'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H975903111">
         <span class="h2">
          Inflammatory fluid collections
         </span>
         <span class="headingEndMark">
          —
         </span>
         These are not true epithelial cysts and typically represent local complications of acute pancreatitis. Inflammatory fluid collections were previously grouped together under the heading of pancreatic pseudocysts. In 2013, a revision of the Atlanta classification of acute pancreatitis was published that updated the terminology used to describe pancreatic fluid collections to better reflect the underlying pathophysiology [
         <a href="#rid5">
          5
         </a>
         ]. According to the revised Atlanta classification, inflammatory fluid collections include acute peripancreatic fluid collections, pseudocysts, acute necrotic collections, and walled-off pancreatic necrosis [
         <a href="#rid5">
          5
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acute peripancreatic fluid collections occur in the setting of acute interstitial pancreatitis within four weeks of the onset of pancreatitis. They are typically extra-pancreatic and do not have a definable wall. The fluid contains no solid material, and there is no pancreatic necrosis present.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pseudocysts represent more mature fluid collections that are usually outside the pancreas (though they may be intrapancreatic). They typically develop at least four weeks after acute pancreatitis. They have a well-defined wall, and as is the case with acute peripancreatic fluid collections, there should be no solid material or pancreatic necrosis present. Pseudocysts may also develop following pancreatic trauma.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acute necrotic collections occur in the setting of necrotizing pancreatitis, may be adjacent to or involve the pancreas, have no definable wall, and may contain both liquid and solid material.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Walled-off pancreatic necrosis is a mature (typically developing at least four weeks after acute pancreatitis), encapsulated collection of pancreatic necrosis that may contain liquid and solid elements (with or without loculation). They may be intra- or extra-pancreatic.
        </p>
        <p>
        </p>
        <p>
         It is important to remember that PCNs can sometimes cause acute pancreatitis, or patients presenting with acute pancreatitis may harbor an incidental PCN. As such, all cysts discovered at the time of acute pancreatitis cannot be assumed to be inflammatory. Review of prior imaging if available, clinical presentation and radiological features, and follow-up are important to make this distinction.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          NON-NEOPLASTIC PANCREATIC CYSTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Non-neoplastic pancreatic cysts (NNPCs) include a variety of very rare cysts that are often asymptomatic and do not require resection. These include true cysts, acinar cystic transformation of the pancreas, retention cysts, mucinous non-neoplastic cysts, and lymphoepithelial cysts. They are typically diagnosed after surgical resection of a lesion that was thought to be a pancreatic cystic neoplasm (PCN) preoperatively.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          True cysts
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are only a few cases reported of true cysts or "benign epithelial cysts" of the pancreas. These cystic lesions with a cuboidal epithelial lining have an unclear natural history.
        </p>
        <p class="headingAnchor" id="H1595202229">
         <span class="h2">
          Acinar cystic transformation of the pancreas
         </span>
         <span class="headingEndMark">
          —
         </span>
         Also known as acinar cell cystadenomas, these are exceedingly rare lesions. These are believed to be non-neoplastic lesions lined by benign acinar and ductal epithelium that may occur anywhere in the pancreas, but usually in the pancreatic head in females. Usually incidentally discovered, these may grow and lead to symptoms due to space occupation. Usually confused for other cystic lesions, the diagnosis is only made after resection [
         <a href="#rid6">
          6,7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Retention cysts
         </span>
         <span class="headingEndMark">
          —
         </span>
         Retention cysts are small dilated pancreatic duct side branches arising due to obstruction (eg, from pancreatic intraepithelial neoplasia or from inspissated protein debris seen in association with chronic pancreatitis or cystic fibrosis).
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Mucinous non-neoplastic cysts
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mucinous non-neoplastic cysts are exceedingly difficult to differentiate from PCNs. Like PCNs, mucinous non-neoplastic cysts are lined with a mucinous lining, but they lack any neoplastic features (eg, atypia) or ductal communication [
         <a href="#rid8">
          8
         </a>
         ]. These lesions have an unclear natural history.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Lymphoepithelial cysts
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lymphoepithelial cysts (LEC) are rare, benign, and usually asymptomatic cystic lesions. Often described as peripancreatic, these lesions are lined by mature keratinizing squamous epithelium surrounded by a distinct layer of lymphoid tissue [
         <a href="#rid9">
          9
         </a>
         ]. Endoscopic ultrasound with fine needle aspiration (EUS-FNA) may be required to differentiate an LEC from a PCN. FNA cytology usually reveals characteristic epithelial cells and small, mature lymphocytes in a background of keratinaceous debris, anucleate squamous cells, and multinucleated histiocytes [
         <a href="#rid10">
          10
         </a>
         ]. Resection is recommended in symptomatic cases, but not for asymptomatic patients.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          PANCREATIC CYSTIC NEOPLASMS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Identifying pancreatic cystic neoplasms (PCNs) is important, since some have malignant potential. PCNs are categorized using the WHO histological classification [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
         There are six subtypes of PCNs:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serous neoplasms
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mucinous cystic neoplasms (MCNs)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intraductal papillary mucinous neoplasms (IPMNs)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intraductal oncocytic papillary neoplasms (IOPNs)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intraductal tubulopapillary neoplasms (ITPNs)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Solid pseudopapillary neoplasms (SPNs)
        </p>
        <p>
        </p>
        <p>
         The key demographic and clinical features of PCNs are summarized in the table  (
         <a class="graphic graphic_table graphicRef57759" href="/z/d/graphic/57759.html" rel="external">
          table 1
         </a>
         ). Each of the subtypes has benign and malignant forms.
        </p>
        <p>
         The relative frequencies of the different PCNs were examined in a retrospective series of 851 patients undergoing surgical resection for a cystic neoplasm of the pancreas between 1978 and 2011 [
         <a href="#rid12">
          12
         </a>
         ]. Intraductal papillary mucinous neoplasms accounted for 38 percent of lesions, mucinous cystic neoplasms for 23 percent, serous cystic tumors for 16 percent, and solid pseudopapillary neoplasms for 3 percent. When only the 376 patients who had surgery between 2005 and 2011 were considered, 49 percent had intraductal papillary mucinous neoplasms, 16 percent had mucinous cystic neoplasms, 12 percent had serous cystic tumors, and 5 percent had solid pseudopapillary neoplasms. However, this series is subject to sampling bias, as it only evaluated resected PCNs. Most branch duct IPMNs and serous cystadenomas do not require resection; thus, the relative frequency of these lesions may have been underestimated.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Serous neoplasms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most serous neoplasms are serous cystadenomas, which are benign neoplasms lined by glycogen-rich cuboidal cells that originate from pancreatic centro-acinar cells  (
         <a class="graphic graphic_diagnosticimage graphicRef66608" href="/z/d/graphic/66608.html" rel="external">
          image 1
         </a>
         and
         <a class="graphic graphic_picture graphicRef61511" href="/z/d/graphic/61511.html" rel="external">
          picture 1
         </a>
         ). These lesions can arise anywhere in the pancreas and are most commonly diagnosed in women over the age 60 years [
         <a href="#rid13">
          13-15
         </a>
         ].
        </p>
        <p>
         The WHO classifies serous neoplasms of the pancreas as microcystic serous cystadenoma, macrocystic (oligocystic) serous cystadenoma, solid serous adenoma, von Hippel-Lindau syndrome-associated serous cystic neoplasm, and mixed serous-neuroendocrine neoplasm [
         <a href="#rid11">
          11
         </a>
         ]. For clinical purposes and in the non-
         <em>
          VHL
         </em>
         population, the most commonly encountered are microcystic serous cystadenomas, which are composed of multiple small cystic spaces  (
         <a class="graphic graphic_picture graphicRef73288 graphicRef82546 graphicRef71673" href="/z/d/graphic/73288.html" rel="external">
          picture 2A-C
         </a>
         ), and oligocystic serous cystadenomas, which are composed of fewer, larger cysts [
         <a href="#rid16">
          16-18
         </a>
         ]. The oligocystic variant can be difficult to distinguish from an MCN or branch duct IPMN, which can have a similar appearance. Unless symptomatic, these can be followed conservatively since malignant degeneration is exceedingly rare. (See
         <a class="medical medical_review" href="/z/d/html/5642.html" rel="external">
          "Pancreatic cystic neoplasms: Clinical manifestations, diagnosis, and management", section on 'Management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Mucinous cystic neoplasms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mucinous cystic neoplasms (MCNs)  (
         <a class="graphic graphic_picture graphicRef58137 graphicRef66804" href="/z/d/graphic/58137.html" rel="external">
          picture 3A-B
         </a>
         ) occur almost exclusively in women and are most commonly discovered after the age of 40 years [
         <a href="#rid19">
          19
         </a>
         ]. MCNs exhibit variable cellular atypia and secrete mucin similar to IPMNs [
         <a href="#rid20">
          20,21
         </a>
         ]. In contrast to IPMNs, MCNs demonstrate ovarian-like stroma [
         <a href="#rid22">
          22
         </a>
         ], typically arise in the pancreatic tail or body  (
         <a class="graphic graphic_picture graphicRef52386" href="/z/d/graphic/52386.html" rel="external">
          picture 4
         </a>
         ) [
         <a href="#rid21">
          21
         </a>
         ], and do not communicate with the pancreatic duct. (See
         <a class="local">
          'Intraductal papillary mucinous neoplasms'
         </a>
         below.)
        </p>
        <p>
         Due to the risk of malignancy developing, resection is recommended in appropriate candidates. However, in the absence of mural nodules, malignancy is rarely found in cysts &lt;4 cm in size [
         <a href="#rid22">
          22-24
         </a>
         ]. Thus, the patient's age and health status need to be considered when making management decisions. (See
         <a class="medical medical_review" href="/z/d/html/5642.html" rel="external">
          "Pancreatic cystic neoplasms: Clinical manifestations, diagnosis, and management", section on 'Management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Intraductal papillary mucinous neoplasms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intraductal papillary mucinous neoplasms (IPMNs) are mucin-producing papillary neoplasms of the pancreatic ductal system that exhibit variable cellular atypia and cause dilation of the pancreatic ducts [
         <a href="#rid25">
          25
         </a>
         ]. IPMNs have an equal sex distribution, with incidence peaking over the age of 50 years [
         <a href="#rid26">
          26
         </a>
         ]. They are the most commonly encountered cystic neoplasm.
        </p>
        <p>
         IPMNs may involve the main pancreatic duct (main duct IPMN)  (
         <a class="graphic graphic_diagnosticimage graphicRef51921" href="/z/d/graphic/51921.html" rel="external">
          image 2
         </a>
         ), its side branches (branch duct IPMN), or both (mixed-type IPMN)  (
         <a class="graphic graphic_diagnosticimage graphicRef101892" href="/z/d/graphic/101892.html" rel="external">
          image 3
         </a>
         ). They are often multifocal or diffuse, and can extend microscopically from the clinically apparent lesions.
        </p>
        <p>
         The characteristic pathologic features include the diffuse or segmental dilation of the pancreatic duct without stricturing, the intraductal expansion of mucin-producing ductal cells (which may be flat or project into the lumen), and the dilation of either one or both pancreatic orifices, through which there is a copious secretion of mucus  (
         <a class="graphic graphic_picture graphicRef52643" href="/z/d/graphic/52643.html" rel="external">
          picture 5
         </a>
         ).
        </p>
        <p>
         Histologically, the columnar mucin-producing cells can be hyperplastic or dysplastic. They can be further classified based upon the degree of dysplasia exhibited by the epithelial cells as low-grade dysplasia, high-grade dysplasia, or invasive cancer [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2502534208">
         <span class="h2">
          Intraductal oncocytic papillary neoplasms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intraductal oncocytic papillary neoplasms (IOPNs) are rare, representing approximately 5 percent of all intraductal neoplasms, and occur more commonly in females. The majority occur in the head of the pancreas, and involve the main pancreatic duct, although they can also involve the branch ducts [
         <a href="#rid27">
          27
         </a>
         ]
        </p>
        <p>
         These tumors form branching papillae composed of cuboidal to columnar cells, with a fibrovascular core. Most IOPNs harbor high-grade dysplasia, but rarely progress to invasive cancer. The overall survival rate is excellent [
         <a href="#rid28">
          28,29
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H396788130">
         <span class="h2">
          Intraductal tubulopapillary neoplasms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intraductal tubulopapillary neoplasms are even more rare than IOPN, accounting for approximately 3 percent of intraductal neoplasms, and are slightly more common in females. These neoplasms tend to form fleshy nodular lesions composed of tubular glands in cribriform architecture. They grow in dilated ducts, with resultant duct occlusion. There is typically no mucinous fluid production and less cystic formation. Even if invasive cancer is present, prognosis is significantly better than that of ductal adenocarcinoma [
         <a href="#rid29">
          29-31
         </a>
         ]. Management involves a combination of surveillance and resection depending upon the risk of malignancy and patient-related factors [
         <a href="#rid32">
          32
         </a>
         ]. IOPN and ITPN are newer pathologic classifications, however, from a clinical standpoint, they are managed similarly to IPMN. (See
         <a class="medical medical_review" href="/z/d/html/16137.html" rel="external">
          "Intraductal papillary mucinous neoplasm of the pancreas (IPMN): Evaluation and management", section on 'Management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Solid pseudopapillary neoplasms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Solid pseudopapillary neoplasms (SPNs) of the pancreas are rare neoplasms that typically occur in young women less than 35 years of age. They have also been called solid and papillary epithelial neoplasms, papillary cystic tumors of the pancreas, and solid and cystic tumors.
        </p>
        <p>
         SPNs are most commonly found in the body or tail of the pancreas and may contain both solid and cystic components and occasional calcifications  (
         <a class="graphic graphic_diagnosticimage graphicRef76413" href="/z/d/graphic/76413.html" rel="external">
          image 4
         </a>
         and
         <a class="graphic graphic_picture graphicRef63887" href="/z/d/graphic/63887.html" rel="external">
          picture 6
         </a>
         ) [
         <a href="#rid33">
          33,34
         </a>
         ]. Due to malignant risk, it is recommended that SPNs be resected. (See
         <a class="medical medical_review" href="/z/d/html/5642.html" rel="external">
          "Pancreatic cystic neoplasms: Clinical manifestations, diagnosis, and management", section on 'Management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Malignant potential
         </span>
         <span class="headingEndMark">
          —
         </span>
         The malignant potential of pancreatic cystic neoplasms is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5642.html" rel="external">
          "Pancreatic cystic neoplasms: Clinical manifestations, diagnosis, and management", section on 'Management'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16137.html" rel="external">
          "Intraductal papillary mucinous neoplasm of the pancreas (IPMN): Evaluation and management", section on 'Prognosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          CYSTIC DEGENERATION IN SOLID PANCREATIC TUMORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cystic degeneration has been described in most solid pancreatic tumors, including endocrine tumors, ductal carcinoma, and acinar cell carcinoma. These lesions are managed similarly to the malignancies from which they arise. (See appropriate topic reviews).
        </p>
        <p class="headingAnchor" id="H812371950">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/111990.html" rel="external">
          "Society guideline links: Pancreatic cysts"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cystic lesions of the pancreas may be divided pathologically into inflammatory fluid collections, non-neoplastic pancreatic cysts, and pancreatic cystic neoplasms (PCNs). In addition, solid tumors may develop cystic degeneration. (See
         <a class="local">
          'Types of pancreatic cysts'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There are six subtypes of PCNs with varying degrees of malignant potential  (
         <a class="graphic graphic_table graphicRef69594" href="/z/d/graphic/69594.html" rel="external">
          table 2
         </a>
         and
         <a class="graphic graphic_table graphicRef57759" href="/z/d/graphic/57759.html" rel="external">
          table 1
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Serous neoplasms
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Mucinous cystic neoplasms (MCNs)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Intraductal papillary mucinous neoplasms (IPMNs)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Intraductal oncocytic papillary neoplasms (IOPNs)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Intraductal tubulopapillary neoplasms (ITPNs)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Solid pseudopapillary neoplasms (SPNs)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Differentiating PCNs from other cystic lesion, as well as determining the subtype of PCN, is important for assessing malignant potential. While serous cystadenomas have almost no malignant potential, the mucin producing PCNs (MCNs and intraductal neoplasms) and SPNs do. (See
         <a class="local">
          'Non-neoplastic pancreatic cysts'
         </a>
         above and
         <a class="local">
          'Pancreatic cystic neoplasms'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Moris M, Bridges MD, Pooley RA, et al. Association Between Advances in High-Resolution Cross-Section Imaging Technologies and Increase in Prevalence of Pancreatic Cysts From 2005 to 2014. Clin Gastroenterol Hepatol 2016; 14:585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kromrey ML, Bülow R, Hübner J, et al. Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut 2018; 67:138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández-del Castillo C, Targarona J, Thayer SP, et al. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg 2003; 138:427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hammel PR, Vilgrain V, Terris B, et al. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau. Gastroenterology 2000; 119:1087.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62:102.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zamboni G, Terris B, Scarpa A, et al. Acinar cell cystadenoma of the pancreas: a new entity? Am J Surg Pathol 2002; 26:698.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singhi AD, Norwood S, Liu TC, et al. Acinar cell cystadenoma of the pancreas: a benign neoplasm or non-neoplastic ballooning of acinar and ductal epithelium? Am J Surg Pathol 2013; 37:1329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kosmahl M, Egawa N, Schröder S, et al. Mucinous nonneoplastic cyst of the pancreas: a novel nonneoplastic cystic change? Mod Pathol 2002; 15:154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramsden KL, Newman J. Lymphoepithelial cyst of the pancreas. Histopathology 1991; 18:267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nasr J, Sanders M, Fasanella K, et al. Lymphoepithelial cysts of the pancreas: an EUS case series. Gastrointest Endosc 2008; 68:170.
          </a>
         </li>
         <li class="breakAll">
          Gill AJ, Klimstra DS, Lam AK, et al.. Tumours of the pancreas. In: World Health Organization Classification of Tumours, 5, WHO Classification of Tumours Editorial Board (Ed), IARC Press, Lyon 2019. p.296.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valsangkar NP, Morales-Oyarvide V, Thayer SP, et al. 851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. Surgery 2012; 152:S4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Compagno J, Oertel JE. Microcystic adenomas of the pancreas (glycogen-rich cystadenomas): a clinicopathologic study of 34 cases. Am J Clin Pathol 1978; 69:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pyke CM, van Heerden JA, Colby TV, et al. The spectrum of serous cystadenoma of the pancreas. Clinical, pathologic, and surgical aspects. Ann Surg 1992; 215:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lundstedt C, Dawiskiba S. Serous and mucinous cystadenoma/cystadenocarcinoma of the pancreas. Abdom Imaging 2000; 25:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brugge WR, Lauwers GY, Sahani D, et al. Cystic neoplasms of the pancreas. N Engl J Med 2004; 351:1218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewandrowski K, Warshaw A, Compton C. Macrocystic serous cystadenoma of the pancreas: a morphologic variant differing from microcystic adenoma. Hum Pathol 1992; 23:871.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gouhiri M, Soyer P, Barbagelatta M, Rymer R. Macrocystic serous cystadenoma of the pancreas: CT and endosonographic features. Abdom Imaging 1999; 24:72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brugge WR. Diagnosis and management of cystic lesions of the pancreas. J Gastrointest Oncol 2015; 6:375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarr MG, Carpenter HA, Prabhakar LP, et al. Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg 2000; 231:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zamboni G, Scarpa A, Bogina G, et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 1999; 23:410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reddy RP, Smyrk TC, Zapiach M, et al. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol 2004; 2:1026.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crippa S, Fernández-Del Castillo C, Salvia R, et al. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol 2010; 8:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crippa S, Salvia R, Warshaw AL, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg 2008; 247:571.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Angelica M, Brennan MF, Suriawinata AA, et al. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg 2004; 239:400.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004; 239:788.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Onofrio M, De Robertis R, Tinazzi Martini P, et al. Oncocytic Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Histopathological Findings. Pancreas 2016; 45:1233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang T, Askan G, Adsay V, et al. Intraductal Oncocytic Papillary Neoplasms: Clinical-Pathologic Characterization of 24 Cases, With An Emphasis on Associated Invasive Carcinomas. Am J Surg Pathol 2019; 43:656.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020; 76:182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamaguchi H, Shimizu M, Ban S, et al. Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2009; 33:1164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Basturk O, Adsay V, Askan G, et al. Intraductal Tubulopapillary Neoplasm of the Pancreas: A Clinicopathologic and Immunohistochemical Analysis of 33 Cases. Am J Surg Pathol 2017; 41:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jung W, Park T, Kim Y, et al. Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10 mm or less. Br J Surg 2019; 106:1829.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Master SS, Savides TJ. Diagnosis of solid-pseudopapillary neoplasm of the pancreas by EUS-guided FNA. Gastrointest Endosc 2003; 57:965.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mergener K, Detweiler SE, Traverso LW. Solid pseudopapillary tumor of the pancreas: diagnosis by EUS-guided fine-needle aspiration. Endoscopy 2003; 35:1083.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5637 Version 26.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26370569" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Association Between Advances in High-Resolution Cross-Section Imaging Technologies and Increase in Prevalence of Pancreatic Cysts From 2005 to 2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28877981" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12686529" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11040195" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23100216" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12023573" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Acinar cell cystadenoma of the pancreas: a new entity?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24076773" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Acinar cell cystadenoma of the pancreas: a benign neoplasm or non-neoplastic ballooning of acinar and ductal epithelium?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11850544" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Mucinous nonneoplastic cyst of the pancreas: a novel nonneoplastic cystic change?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1710596" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Lymphoepithelial cyst of the pancreas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18513719" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Lymphoepithelial cysts of the pancreas: an EUS case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18513719" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Lymphoepithelial cysts of the pancreas: an EUS case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22770958" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : 851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/637043" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Microcystic adenomas of the pancreas (glycogen-rich cystadenomas): a clinicopathologic study of 34 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1546898" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : The spectrum of serous cystadenoma of the pancreas. Clinical, pathologic, and surgical aspects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10675468" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Serous and mucinous cystadenoma/cystadenocarcinoma of the pancreas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15371579" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Cystic neoplasms of the pancreas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1644432" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Macrocystic serous cystadenoma of the pancreas: a morphologic variant differing from microcystic adenoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9933678" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Macrocystic serous cystadenoma of the pancreas: CT and endosonographic features.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26261724" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Diagnosis and management of cystic lesions of the pancreas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10674612" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10199470" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15551256" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19835989" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18362619" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15075659" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15166958" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27518461" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Oncocytic Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Histopathological Findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30986801" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Intraductal Oncocytic Papillary Neoplasms: Clinical-Pathologic Characterization of 24 Cases, With An Emphasis on Associated Invasive Carcinomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31433515" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : The 2019 WHO classification of tumours of the digestive system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19440145" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27984235" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Intraductal Tubulopapillary Neoplasm of the Pancreas: A Clinicopathologic and Immunohistochemical Analysis of 33 Cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31441048" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10 mm or less.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12776058" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Diagnosis of solid-pseudopapillary neoplasm of the pancreas by EUS-guided FNA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14648429" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Solid pseudopapillary tumor of the pancreas: diagnosis by EUS-guided fine-needle aspiration.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
